* The 5-Year EBITDA Growth Rate is the 5-year average EBITDA per share growth rate. While the denominator is a percentage, we use the whole number as opposed to the decimal form for the calculation. For example, 5% would be shown as 5 as opposed to 0.05. If it's smaller than or equal to 0, then the PEG Ratio is not calculated.
The historical rank and industry rank for Noevir Holdings Co's PEG Ratio or its related term are showing as below:
TSE:4928'
s PEG Ratio Range Over the Past 10 Years
Min: 1.29 Med: 3.17 Max: 82.8
Current: 28.04
During the past 13 years, Noevir Holdings Co's highest PEG Ratio was 82.80. The lowest was 1.29. And the median was 3.17.
TSE:4928's PEG Ratio is ranked worse than 96.01% of 727
companies
in the Consumer Packaged Goods industry
Industry Median: 1.46
vs TSE:4928: 28.04
Peter Lynch thinks a company with a P/E ratio equal to its growth rate is fairly valued.
Noevir Holdings Co PEG Ratio Historical Data
The historical data trend for Noevir Holdings Co's PEG Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Noevir Holdings Co's PEG Ratio
For the Household & Personal Products subindustry, Noevir Holdings Co's PEG Ratio, along with its competitors' market caps and PEG Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Noevir Holdings Co's PEG Ratio Distribution in the Consumer Packaged Goods Industry
For the Consumer Packaged Goods industry and Consumer Defensive sector, Noevir Holdings Co's PEG Ratio distribution charts can be found below:
* The bar in red indicates where Noevir Holdings Co's PEG Ratio falls into.
Noevir Holdings Co PEG Ratio Calculation
PEG Ratio is defined as the PE Ratio without NRI divided by the growth ratio.
The ratio we use is the 5-Year EBITDA growth rate.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
* Note: The 5-Year EBITDA Growth Rate is the 5-year average EBITDA per share growth rate. While the denominator is a percentage, we use the whole number as opposed to the decimal form for the calculation. For example, 5% would be shown as 5 as opposed to 0.05. If it's smaller than or equal to 0, then the PEG Ratio is not calculated.
Noevir Holdings Co (TSE:4928) PEG Ratio Explanation
To compare stocks with different growth rates, Peter Lynch invented a ratio called PEG Ratio. PEG Ratio is defined as the P/E ratio divided by the growth ratio. He thinks a company with a P/E ratio equal to its growth rate is fairly valued. Still he said he would rather buy a company growing 20% a year with a P/E of 20, instead of a company growing 10% a year with a P/E of 10.
Noevir Holdings Co PEG Ratio Related Terms
Thank you for viewing the detailed overview of Noevir Holdings Co's PEG Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.
Noevir Holdings Co Ltd is a Japan-based company that is principally engaged in two businesses, cosmetics, and pharmaceuticals and health food. The cosmetics business produces and offers skincare and makeup products under a number brands, like Noevir, NOV, and Sana. The pharmaceuticals and health food business develops, produces and sells a broad range of products, including Nanten Nodo Ame cough drops, functional drinks, and other over-the-counter pharmaceuticals, such as cold remedies and eye drops, and health food products as well. These two businesses jointly contribute the majority of the company's revenue. The company also operates apparel and aircraft sales and leasing. The company has a presence in a number of countries across the world, and focuses on developing Asian markets.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
TSE:4928 has been successfully added to your 